Cargando…
Leveraging Immunopeptidomics To Study and Combat Infectious Disease
T cells must recognize pathogen-derived peptides bound to major histocompatibility complexes (MHCs) in order to initiate a cell-mediated immune response against an infection, or to support the development of high-affinity antibody responses. Identifying antigens presented on MHCs by infected cells a...
Autores principales: | Leddy, Owen K., White, Forest M., Bryson, Bryan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407116/ https://www.ncbi.nlm.nih.gov/pubmed/34342538 http://dx.doi.org/10.1128/mSystems.00310-21 |
Ejemplares similares
-
Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I
por: Leddy, Owen, et al.
Publicado: (2023) -
New approaches to combating antimicrobial drug resistance
por: Avison, Matthew B
Publicado: (2005) -
Signaling netwErks get the global treatment
por: Yaffe, Michael B, et al.
Publicado: (2007) -
Quantitative Consequences of Protein Carriers in Immunopeptidomics and Tyrosine Phosphorylation MS(2) Analyses
por: Stopfer, Lauren E., et al.
Publicado: (2021) -
Genome-wide association studies are coming for human infectious diseases
por: Davila, Sonia, et al.
Publicado: (2009)